FONDECYT REGULAR 1181853 (ANID-Chile)
“Identifying immunodominant T-cell antigen-peptides and T-cell responses in rheumatoid arthritis: A further step in the development of an antigen-specific dendritic cell-based therapy to restore self-tolerance”.
2018-2022. Principal Investigator: Dr. Juan Carlos Aguillón.